[EN] COMPOUNDS AND METHODS [FR] COMPOSÉS ET MÉTHODES
摘要:
本发明涉及新型视黄醇相关孤儿受体γ(RORγ)调节剂及其在治疗由RORγ介导的疾病中的应用。
公开号:
WO2013019635A1
作为产物:
描述:
对羟基苯乙酸 、 (4-chlorophenyl)(2,4-dimethylphenyl)methanamine 、 在
silica gel 、 ethyl acetate hexanes 作用下,
以to provide the title compound (0.81 g, 43.78%)的产率得到N-((4-chlorophenyl)(2,4-dimethylphenyl)methyl)-2-(4-hydroxyphenyl)acetamide
[EN] COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET MÉTHODES
申请人:TEMPERO PHARMACEUTICALS INC
公开号:WO2013019635A1
公开(公告)日:2013-02-07
The present invention relates to novel retinoid-reiated orphan receptor gamma (RORy) modulators and their use in the treatment of diseases mediated by RORy.